Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L17 pseudogene 7 is a processed pseudogene derived from the functional gene encoding ribosomal protein L17. Like most ribosomal protein pseudogenes, RPL17P7 arose via reverse transcription and integration of mRNA from the parent RPL17 gene into the genome, but it is generally nonfunctional and does not produce a protein. While the parent gene, ribosomal protein L17, is involved in the structure and function of the large ribosomal subunit, pseudogenes such as RPL17P7 are usually considered non-coding and lack direct biological activity. Pseudogenes can sometimes play regulatory roles, but no specific regulatory or pathological role is documented for RPL17P7.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L17 pseudogene 7 (RPL17P7).